Genome Wide Association Study of the Kynurenine Pathway

Abstract The kynurenine pathway (KP) of tryptophan metabolism plays a key role in physiological processes such as neuronal modulation, aging and immunity. Although genome-wide association studies (GWAS) have identified genetic determinants of selected kynurenine metabolites, the genetic architecture of the pathway as a whole remains incompletely characterized. We performed GWAS on nine KP metabolites and seven biologically informed metabolite-ratios measured by targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 4,871 unrelated individuals of Norwegian ancestry from the Hordaland Health Study. We identified 23 independent metabolite-associated loci (mQTLs), including associations for all measured metabolites covering all enzymes in the initial part of the pathway. Many signals replicated known loci at key pathway genes, including IDO1/2, AFMID, KMO, KYNU, HAAO, AADAT while revealing how their effects propagate across multiple pathway intermediates and ratios. Genetic associations were highly consistent with established pathway biology, with enzyme-specific loci predominantly affecting metabolites immediately upstream or downstream of the corresponding reaction. Ratio-based analyses identified additional hits not found by single-metabolite GWAS, reflecting pathway balance and vitamin B6-dependent enzymatic activity. Integration with expression quantitative trait locus data supported a dose-dependent role of KMO expression in regulating the kynurenic acid/quinolinic acid balance. We also identified novel loci that may represent important amino acid metabolism-immune crosstalk in the regulation of KP and previously unrecognized links with fatty acid oxidation, phase II transformation and metabolite efflux processes. Together, the study provides a comprehensive pathway-level view of the genetic determinants for circulating kynurenines and their ratios within a Northern European population.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-10957011/v1
Primary Topic
Tryptophan and brain disorders
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Genome Wide Association Study of the Kynurenine Pathway

Øyvind Helgeland, Pål R. Njølstad, Adrian McCann, Arve Ulvik et al.
Research Square
Tryptophan and brain disorders
preprint

Genome Wide Association Study of the Kynurenine Pathway

Øyvind Helgeland, Pål R. Njølstad, Adrian McCann, Arve Ulvik, Per Magne Ueland, Tore Ivar Malmei Aarsland, Jan Haavik, Rolv Terje Lie, Ottar Kjell Nygard, Stefan Johansson, Grete Seppola Tell, Chinh B’krong Nguyen
preprint en

Abstract

Abstract The kynurenine pathway (KP) of tryptophan metabolism plays a key role in physiological processes such as neuronal modulation, aging and immunity. Although genome-wide association studies (GWAS) have identified genetic determinants of selected kynurenine metabolites, the genetic architecture of the pathway as a whole remains incompletely characterized. We performed GWAS on nine KP metabolites and seven biologically informed metabolite-ratios measured by targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 4,871 unrelated individuals of Norwegian ancestry from the Hordaland Health Study. We identified 23 independent metabolite-associated loci (mQTLs), including associations for all measured metabolites covering all enzymes in the initial part of the pathway. Many signals replicated known loci at key pathway genes, including IDO1/2, AFMID, KMO, KYNU, HAAO, AADAT while revealing how their effects propagate across multiple pathway intermediates and ratios. Genetic associations were highly consistent with established pathway biology, with enzyme-specific loci predominantly affecting metabolites immediately upstream or downstream of the corresponding reaction. Ratio-based analyses identified additional hits not found by single-metabolite GWAS, reflecting pathway balance and vitamin B6-dependent enzymatic activity. Integration with expression quantitative trait locus data supported a dose-dependent role of KMO expression in regulating the kynurenic acid/quinolinic acid balance. We also identified novel loci that may represent important amino acid metabolism-immune crosstalk in the regulation of KP and previously unrecognized links with fatty acid oxidation, phase II transformation and metabolite efflux processes. Together, the study provides a comprehensive pathway-level view of the genetic determinants for circulating kynurenines and their ratios within a Northern European population.

Research Square
Haukeland University Hospital (NO), Bevital (Norway) (NO), University of Bergen (NO)
Norges Teknisk-Naturvitenskapelige Universitet, Novo Nordisk, Helse Vest, Universitetet i Bergen, Norges Forskningsråd, Bergens Forskningsstiftelse
Good health and well-being
Tryptophan and brain disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon